Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ovarian Cancer
Dendritic Cell-Based Vaccine Evaluated
May 6th, 2000
Researchers in the United States and Italy have evaluated an anti-cancer vaccine for its efficacy against ovarian cancer. Allessandro D. Santin and colleagues from the University of Arkansas and the Arkansas Cancer Research Center, Arkansas, USA, and the University of Brescia, Italy, assessed tumor-specific cytotoxic T-cell responses elicited by dendritic cell (DC)-based vaccines in patients with advanced ovarian cancer. Santin et al. presented data from their study at the 31st Annual Meeting of the Society of Gynecological Oncologists, held in San Diego, California. The title of their presentation was "Induction of tumor-specific CD8+...
Source: Women's Health Weekly (2000-05-06)
|
